BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $137,000 | +6.2% | 4,275 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $129,000 | -83.8% | 4,275 | -76.8% | 0.00% | -88.5% |
| Q4 2020 | $798,000 | +231.1% | 18,435 | +312.4% | 0.03% | +100.0% |
| Q3 2020 | $241,000 | -11.7% | 4,470 | 0.0% | 0.01% | -23.5% |
| Q2 2020 | $273,000 | +25.2% | 4,470 | -5.7% | 0.02% | -10.5% |
| Q1 2020 | $218,000 | -81.4% | 4,740 | -64.4% | 0.02% | -70.8% |
| Q4 2019 | $1,170,000 | -11.8% | 13,330 | -7.7% | 0.06% | +1.6% |
| Q3 2019 | $1,327,000 | +21.1% | 14,440 | +67.5% | 0.06% | +10.3% |
| Q2 2019 | $1,096,000 | -19.2% | 8,620 | 0.0% | 0.06% | -21.6% |
| Q1 2019 | $1,356,000 | +115.9% | 8,620 | +36.4% | 0.07% | +105.6% |
| Q4 2018 | $628,000 | -27.3% | 6,320 | +6.8% | 0.04% | -12.2% |
| Q3 2018 | $864,000 | -3.0% | 5,920 | +4.4% | 0.04% | -34.9% |
| Q2 2018 | $891,000 | +4589.5% | 5,670 | +2735.0% | 0.06% | – |
| Q4 2014 | $19,000 | +171.4% | 200 | 0.0% | 0.00% | – |
| Q3 2014 | $7,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |